Kymera Therapeutics Inc (KYMR)
US$ 44.360.29%
Price Chart
Key Statistics
Market Cap
$ 1.95B
P/E Ratio
0.00
Revenue (TTM)
$ 58.89M
Volume
907.31K
52W High
$ 53.27
52W Low
$ 19.45
Dividend Yield
0.00%
Beta
2.19
Technicals
50-Day MA
29.9741
200-Day MA
40.0899
52 Week High
53.27
52 Week Low
19.445
About KYMR
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing.
Employees
208
Headquarters
Watertown, MA
CEO
Dr. Bruce L. Booth DPHIL, Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg